Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 85

1.

The temozolomide derivative 2T-P400 inhibits glioma growth via administration route of intravenous injection.

Li R, Tang D, Zhang J, Wu J, Wang L, Dong J.

J Neurooncol. 2014 Jan;116(1):25-30. doi: 10.1007/s11060-013-1255-7. Epub 2013 Sep 25.

PMID:
24065569
[PubMed - in process]
2.

Local delivery of slow-releasing temozolomide microspheres inhibits intracranial xenograft glioma growth.

Dong J, Zhou G, Tang D, Chen Y, Cui B, Dai X, Zhang J, Lan Q, Huang Q.

J Cancer Res Clin Oncol. 2012 Dec;138(12):2079-84. doi: 10.1007/s00432-012-1290-3. Epub 2012 Jul 24.

PMID:
22825126
[PubMed - indexed for MEDLINE]
3.

[Intranasal administration of temozolomide for brain-targeting delivery: therapeutic effect on glioma in rats].

Li Y, Gao Y, Liu G, Zhou X, Wang Y, Wang Y, Ma L.

Nan Fang Yi Ke Da Xue Xue Bao. 2014 May;34(5):631-5. Chinese.

PMID:
24849425
[PubMed - in process]
Free Article
4.

Metronomic treatment of temozolomide inhibits tumor cell growth through reduction of angiogenesis and augmentation of apoptosis in orthotopic models of gliomas.

Kim JT, Kim JS, Ko KW, Kong DS, Kang CM, Kim MH, Son MJ, Song HS, Shin HJ, Lee DS, Eoh W, Nam DH.

Oncol Rep. 2006 Jul;16(1):33-9.

PMID:
16786120
[PubMed - indexed for MEDLINE]
5.

Combination treatment with temozolomide and thalidomide inhibits tumor growth and angiogenesis in an orthotopic glioma model.

Son MJ, Kim JS, Kim MH, Song HS, Kim JT, Kim H, Shin T, Jeon HJ, Lee DS, Park SY, Kim YJ, Kim JH, Nam DH.

Int J Oncol. 2006 Jan;28(1):53-9.

PMID:
16327979
[PubMed - indexed for MEDLINE]
6.

Inhibition of DNA repair for sensitizing resistant glioma cells to temozolomide.

Kanzawa T, Bedwell J, Kondo Y, Kondo S, Germano IM.

J Neurosurg. 2003 Dec;99(6):1047-52.

PMID:
14705733
[PubMed - indexed for MEDLINE]
7.

Effect of IFN-beta on human glioma cell lines with temozolomide resistance.

Yoshino A, Ogino A, Yachi K, Ohta T, Fukushima T, Watanabe T, Katayama Y, Okamoto Y, Naruse N, Sano E.

Int J Oncol. 2009 Jul;35(1):139-48.

PMID:
19513561
[PubMed - indexed for MEDLINE]
8.

Combination of intracranial temozolomide with intracranial carmustine improves survival when compared with either treatment alone in a rodent glioma model.

Recinos VR, Tyler BM, Bekelis K, Sunshine SB, Vellimana A, Li KW, Brem H.

Neurosurgery. 2010 Mar;66(3):530-7; discussion 537. doi: 10.1227/01.NEU.0000365263.14725.39.

PMID:
20173548
[PubMed - indexed for MEDLINE]
9.

Perillyl alcohol for the treatment of temozolomide-resistant gliomas.

Cho HY, Wang W, Jhaveri N, Torres S, Tseng J, Leong MN, Lee DJ, Goldkorn A, Xu T, Petasis NA, Louie SG, Schönthal AH, Hofman FM, Chen TC.

Mol Cancer Ther. 2012 Nov;11(11):2462-72. doi: 10.1158/1535-7163.MCT-12-0321. Epub 2012 Aug 28.

PMID:
22933703
[PubMed - indexed for MEDLINE]
Free Article
10.

A combination of IFN-beta and temozolomide in human glioma xenograft models: implication of p53-mediated MGMT downregulation.

Natsume A, Wakabayashi T, Ishii D, Maruta H, Fujii M, Shimato S, Ito M, Yoshida J.

Cancer Chemother Pharmacol. 2008 Apr;61(4):653-9. Epub 2007 Jun 13.

PMID:
17564708
[PubMed - indexed for MEDLINE]
11.

Noscapine inhibits tumor growth in TMZ-resistant gliomas.

Jhaveri N, Cho H, Torres S, Wang W, Schönthal AH, Petasis NA, Louie SG, Hofman FM, Chen TC.

Cancer Lett. 2011 Dec 22;312(2):245-52. doi: 10.1016/j.canlet.2011.08.015. Epub 2011 Aug 28.

PMID:
21925789
[PubMed - indexed for MEDLINE]
12.

Gamma-secretase inhibitors enhance temozolomide treatment of human gliomas by inhibiting neurosphere repopulation and xenograft recurrence.

Gilbert CA, Daou MC, Moser RP, Ross AH.

Cancer Res. 2010 Sep 1;70(17):6870-9. doi: 10.1158/0008-5472.CAN-10-1378. Epub 2010 Aug 24.

PMID:
20736377
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Microdialysis measurement of intratumoral temozolomide concentration after cediranib, a pan-VEGF receptor tyrosine kinase inhibitor, in a U87 glioma model.

Grossman R, Tyler B, Rudek MA, Kim E, Zadnik P, Khan U, Blakeley JO, Pathak AP, Brem H.

Cancer Chemother Pharmacol. 2013 Jul;72(1):93-100. doi: 10.1007/s00280-013-2172-3. Epub 2013 May 7.

PMID:
23649683
[PubMed - indexed for MEDLINE]
14.

Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma.

Tentori L, Leonetti C, Scarsella M, D'Amati G, Vergati M, Portarena I, Xu W, Kalish V, Zupi G, Zhang J, Graziani G.

Clin Cancer Res. 2003 Nov 1;9(14):5370-9.

PMID:
14614022
[PubMed - indexed for MEDLINE]
Free Article
15.

A human brainstem glioma xenograft model enabled for bioluminescence imaging.

Hashizume R, Ozawa T, Dinca EB, Banerjee A, Prados MD, James CD, Gupta N.

J Neurooncol. 2010 Jan;96(2):151-9. doi: 10.1007/s11060-009-9954-9. Epub 2009 Jul 8.

PMID:
19585223
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Early assessment of the efficacy of temozolomide chemotherapy in experimental glioblastoma using [18F]FLT-PET imaging.

Viel T, Schelhaas S, Wagner S, Wachsmuth L, Schwegmann K, Kuhlmann M, Faber C, Kopka K, Schäfers M, Jacobs AH.

PLoS One. 2013 Jul 4;8(7):e67911. doi: 10.1371/journal.pone.0067911. Print 2013.

PMID:
23861829
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

A combined preclinical therapy of cannabinoids and temozolomide against glioma.

Torres S, Lorente M, Rodríguez-Fornés F, Hernández-Tiedra S, Salazar M, García-Taboada E, Barcia J, Guzmán M, Velasco G.

Mol Cancer Ther. 2011 Jan;10(1):90-103. doi: 10.1158/1535-7163.MCT-10-0688.

PMID:
21220494
[PubMed - indexed for MEDLINE]
Free Article
18.

Cell cycle-related kinase: a novel candidate oncogene in human glioblastoma.

Ng SS, Cheung YT, An XM, Chen YC, Li M, Li GH, Cheung W, Sze J, Lai L, Peng Y, Xia HH, Wong BC, Leung SY, Xie D, He ML, Kung HF, Lin MC.

J Natl Cancer Inst. 2007 Jun 20;99(12):936-48. Epub 2007 Jun 12.

PMID:
17565152
[PubMed - indexed for MEDLINE]
Free Article
20.

Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus.

Ito H, Aoki H, Kühnel F, Kondo Y, Kubicka S, Wirth T, Iwado E, Iwamaru A, Fujiwara K, Hess KR, Lang FF, Sawaya R, Kondo S.

J Natl Cancer Inst. 2006 May 3;98(9):625-36. Erratum in: J Natl Cancer Inst. 2006 Jun 7;98(11):796.

PMID:
16670388
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk